Regulation of Tissue Plasminogen Activator Secretion from Human Endothelial Cells

  • Eugene G. Levin
  • Keith R. Marotti
  • Lydia Santell
Part of the NATO ASI Series book series (NSSA, volume 191)


Tissue plasminogen activator is produced by cultured cells from a variety of sources, and its production can be regulated by hormones,1–3 tumor promoters,3–5 serine proteases,6 and mediators of inflammation.7 Among the cells producing t-PA is the endothelial cell. One of the proposed functions of the vascular endothelium is to maintain or reestablish a homeostatic environment through a variety of pathways, including the production and release of t-PA. In vivo, t-PA levels are elevated following exercise, venous occlusion, or infusion of DDAVP.8.9 The appearance of t-PA is rapid and transient with the initial increase occurring at or before 30 min and returning to baseline by 5–6 hrs. This pattern of t-PA increase and decrease in blood suggests that it results from a release of stored t-PA. In contrast, stimulation of t-PA release from cultured human endothelial cells by thrombin or histamine is much slower, requiring 4–6 hrs to begin, and is also prolonged, continuing for 12–16 hr and only then declining to baseline levels 6,10 This sequence of events has also been reported in the stimulation of t-PA antigen secretion from other cells such as rat granulosa cells following administration of leutinizing hormone.2,3 Thus, this type of response may be characteristic of hormone-induced release of t-PA antigen and may be important in various physiologic and pathologic events.


Tissue Plasminogen Activator Phorbol Ester Human Endothelial Cell Phorbol Myristate Acetate Antigen Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E. H. Allen, J. A. Hamilton, R. L. Medcalf, M. Kubota, and T. J. Martin, Cyclic AMP-dependent and independent effects on tissue-type plasminogen activator in osteogenic sarcoma cells; evidence from phosphodiesterase inhibition and parathyroid hormone antagonists, Biochim. Biophys. Acta 888: 199 (1986).Google Scholar
  2. 2.
    M. L. O’Connell, R. Canipari, and S. Strickland, Hormonal regulation of tissue plasminogen activator secretion and mRNA levels in rat granulosa cells, J. Biol. Chem. 262: 2339 (1987).Google Scholar
  3. 3.
    T. Ny, Y-X. Liu, M. Ohlsson, P. B. C. Jones, and A. J. W. Hsueh, Regulation of tissue-type plasminogen activator and messenger RNA levels by gonadotropin-releasing hormone in cultured rat granulosa cells and cumulus-oocyte complexes, J Biol Chem 262: 11790 (1987).PubMedGoogle Scholar
  4. 4.
    H. Ashino-Fuse, G. Opdenakker, A. Fuse, and A. Billiau, Mechanisms of the stimulatory effect of phorbol 12-myristate 13-acetate on cellular production of plasminogen activator, Proc Soc Exp Biol Med 176: 109 (1984).PubMedGoogle Scholar
  5. 5.
    E. K. Waller, and W. -D. Schleuning, Induction of fibrinolytic activity in HeLa cells by phorbol myristate acetate: Tissue-type plasminogen activator antigen and mRNA augmentation require intermediate protein biosynthesis, J. Biol. Chem. 260: 6354 (1985).Google Scholar
  6. 6.
    E. G. Levin, U. Marzec, J. Anderson, and L. A. Harker, Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells, J. Clin. Invest. 74: 1988 (1984).Google Scholar
  7. 7.
    M. P. Bevilacqua, R. R. Schleef, M. A. Gimbrone, and D. J. Loskutoff, Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1, J Clin Invest 78: 587 (1986).CrossRefPubMedGoogle Scholar
  8. 8.
    S. Sherry, R. I. Lindemeyer, A. P. Fletcher, and N. J. Alkjaersig,, J. Clin. Invest. 38: 810 (1959).CrossRefPubMedGoogle Scholar
  9. 9.
    P. M. Mannucci, M. Abery, I. M. Nilsson, and B. Robertson,, British J. Haemotol. 30: 81 (1975).CrossRefGoogle Scholar
  10. 10.
    E. G. Levin, and L. Santell, Stimulation and desensitization of tissue plasminogen activator release from human endothelial cells, J Biol Chem 263: 9360 (1988).PubMedGoogle Scholar
  11. 11.
    T. J. Resink, G. Y. Grigorian, A. K. Moldabaeva, S. M. Danilov, and F. R. Buhler, Histamine-induced phosphoinositide metabolism in cultured human umbilical vein endothelial cells. Association with thromboxane and prostacyclin release, Biochem. Biophys. Res. Commun. 144: 438 (1987).Google Scholar
  12. 12.
    S. L. Hong, N. J. McLaughlin, C. -Y. Tzeng, and G. Patton, Prostacyclin synthesis and deacylation of phospholipids in human endothelial cells: Comparison of thrombin, histamine and ionophore A23187, Thromb. Res. 38: 1 (1985).Google Scholar
  13. 13.
    Y. Nishizuka, Studies and perspectives of protein kinase C, Science 233: 305 (1986).CrossRefPubMedGoogle Scholar
  14. 14.
    M. L. Medcalf, E. Van den Berg, and W. -D. Schleuning, Glucocorticoid-modulated gene expression of tissue-and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2, J Cell Biol 106: 971 (1988).CrossRefPubMedGoogle Scholar
  15. 15.
    T. Matsui, Y. Nakao, T. Koizumi, Y. Katakami, and T. Fujita, Inhibition of phorbol ester-induced phenotypic differentiation of HL-60 cells by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, a protein kinase inhibitor, Cancer Res. 46: 583 (1986).PubMedGoogle Scholar
  16. 16.
    R. M. Burch, A. Lin Ma, and J. Axelrod, Phorbol esters and diacylglycerols amplify bradykinin-stimulated prostaglandin synthesis in swiss 3T3 fibroblasts, J Biol Chem 263: 4764 (1988).PubMedGoogle Scholar
  17. 17.
    A. K Ho, C. L. Chik, and D. C. Klein, Effects of protein kinase inhibitor (1-(5- isoquinolinesulfonyl)-2-methylpiperazine (H7) on protein kinase C activity and adrenergic stimulation of cAMP and cGMP in rat pinealocytes, Biochem Pharmacol 37: 1015 (1988).CrossRefPubMedGoogle Scholar
  18. 18.
    M. Castagna, Y. Takai, K. Kaibuchi, K. Sano, U. Kikkawa, and Y. Nishizuka, Direct activation of calcium-activated,phospholipid-dependent protein kinase by tumor-promoting phorbol esters, J Biol Chem 257: 7847 (1982).PubMedGoogle Scholar
  19. 19.
    J. E. Niedel, L. J. Kuhn, and G. R. Vandenbark, Phorbol diester receptor copurifies with protein kinase C, Proc Nail Acad Sci USA 80: 36 (1983).CrossRefGoogle Scholar
  20. 20.
    U. Kikkawa, Y. Takai, Y. Tanaka, R. Miyake, and Y. Nishizuka, Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters, J Biol Chem 258: 11442 (1983).PubMedGoogle Scholar
  21. 21.
    K. L. Leach, M. L. James, and P. M. Blumberg, Characterization of a specific phorbol ester aporeceptor in mouse brain cytosol, Proc Nail Acad Sci USA 80: 4208 (1983).CrossRefGoogle Scholar
  22. 22.
    J. A. Ribes, C. A. Francis, and D. D. Wagner, Fibrin induces release of von Willebrand factor from endothelial cells, J. Clin. Invest. 79: 117 (1987).Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Eugene G. Levin
    • 1
  • Keith R. Marotti
    • 2
  • Lydia Santell
    • 1
  1. 1.Department of Basic and Clinical ResearchScripps Clinic and Research FoundationLa JollaUSA
  2. 2.Department of Molecular BiologyThe UPJOHN CompanyKalamazooUSA

Personalised recommendations